The American Recovery and Reinvestment Act of 2009 provided $1.1 billion for comparative effectiveness research (CER). The Patient Protection and Affordable Care Act established the Patient-Centered ...
Comparative effectiveness research increasingly is being recognized as a priority area in cancer research. Although researchers have been conducting comparative effectiveness research for decades, ...
Rigorous scientific standards are needed to address the challenge of providing information on the real-world effects of treatments and procedures. With enactment of healthcare reform legislation now a ...
The demand for better evidence to guide healthcare decision making is increasing rapidly for a variety of reasons, including the adverse consequences of care administered without adequate evidence, ...
Comparative effectiveness research has been the target of recurrent criticism in some political circles, with opponents claiming it’s the “gateway to rationing” or it encourages “cookbook medicine.” ...
The importance of science advice—broadly defined here as practices for mobilizing scientific knowledge in support of public decision-making—is now widely accepted (OECD, 2015). Over the last decade, ...
In the article that accompanies this editorial, Lu et al 5 conducted a systematic review on the use of instrumental variable (IV) methods in oncology comparative effectiveness research. The main ...
PCORI also is offering up to $200 million through the Phased Large Awards for Comparative Clinical Effectiveness Research (PLACER) PFA, for ambitious, large-scale two-phased trials addressing critical ...
Your institution does not have access to this book on JSTOR. Try searching on JSTOR for other items related to this book. COMPARATIVE STUDIES: A REVIEW WITH SOME PROJECTIONS COMPARATIVE STUDIES: A ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results